Terrillion Scott

Avg. Two Year Performance

No purchase track record
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(< 1%)(5%)(5%)2%0%
Sale Success Rate1 of 101 of 102 of 102 of 100 of 10

Cara Therapeutics, Inc.

Drugs » Biotechnology

Sec'y; Chief Compliance & G.C.:

Holdings: 88.25K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--